Reaction Details Report a problem with these data
Target
Granzyme B
Ligand
BDBM605080
Substrate
n/a
Meas. Tech.
Biochemical Assay
IC50
>5000±n/a nM
Citation
 Bilcer, GM; Kelly, TA Granzyme B directed imaging and therapy US Patent  US11667645 Publication Date 6/6/2023 
Target
Name:
Granzyme B
Synonyms:
CGL1 | CSPB | CTLA1 | GRAB_HUMAN | GRB | GZMB
Type:
PROTEIN
Mol. Mass.:
27735.56
Organism:
Homo sapiens (Human)
Description:
ChEMBL_469245
Residue:
247
Sequence:
MQPILLLLAFLLLPRADAGEIIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHCWGSSINVTLGAHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIELCVGDPEIKKTSFKGDSGGPLVCNKVAQGIVSYGRNNGMPPRACTKVSSFVHWIKKTMKRY
  
Inhibitor
Name:
BDBM605080
Synonyms:
(2S,5S)-5-(2-Acetylamino-acetylamino)- 4-oxo-1,2,4,5,6,7-hexahydro- azepino[3,2,1-hi]indole-2-carboxylic acid (1H-[1,2,3]triazol-4-ylmethyl)- amide | US11667645, Compound C023
Type:
Small organic molecule
Emp. Form.:
C20H23N7O4
Mol. Mass.:
425.4411
SMILES:
CC(=O)NCC(=O)N[C@H]1CCc2cccc3C[C@H](N(c23)C1=O)C(=O)NCc1c[nH]nn1 |r|
Structure:
Search PDB for entries with ligand similarity: